Dr Diana Tran Park, DPM | |
1501 San Pedro Dr Se, Albuquerque, NM 87108-5153 | |
(832) 613-7598 | |
Not Available |
Full Name | Dr Diana Tran Park |
---|---|
Gender | Female |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 1501 San Pedro Dr Se, Albuquerque, New Mexico |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013659887 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213E00000X | Podiatrist | RESIDENT (New Mexico) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | RESIDENT (New Mexico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Diana Tran Park, DPM 1501 San Pedro Dr Se, Albuquerque, NM 87108-5153 Ph: (832) 613-7598 | Dr Diana Tran Park, DPM 1501 San Pedro Dr Se, Albuquerque, NM 87108-5153 Ph: (832) 613-7598 |
News Archive
A study by Japanese researchers has revealed that a certain kind of stress damages the hair - they say "genotoxic stress" damages DNA by depleting the melanocyte stem cells (MSCs) within hair follicles that are responsible for making the pigment-producing cells.
On March 31, 2011, H&Q Healthcare Investors paid a stock distribution of $0.31 per share. It is estimated that this distribution is derived from long-term capital gains.
Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved a label update for ONGLYZA in the treatment of adults with type 2 diabetes who have moderate or severe renal impairment. The approved dosage for the patient group is a new once-daily 2.5 mg dose.
Cedars-Sinai regenerative medicine investigators have received approval from the U.S. Food and Drug Administration to test a combination stem cell-gene therapy they developed to stall the progression of amyotrophic lateral sclerosis, a neurological disease that causes progressive paralysis and ultimately death.
› Verified 2 days ago